Metropolis Healthcare Q2 Results: Profit Jumps 31%, Meets Estimates

Metropolis Healthcare Ltd.'s consolidated net profit rose 31% in the second quarter of fiscal 2025, meeting analysts' estimates.

The diagnostic service provider's profit stood at Rs 46.7 crore in the quarter ended September, compared with Rs 35.7 crore in the same period of the previous fiscal, according to an exchange filing on Friday. The consensus estimate of analysts tracked by Bloomberg stood at Rs 47 crore.

Revenue from operations during the quarter stood at Rs 350 crore, marking a year-on-year growth of 13%. This was driven by sustained growth in patient volumes and test volumes, at 7% and 8%, respectively. The revenue per patient increased by 6%.

• Revenue up 13% to Rs 350 crore (Bloomberg estimate: Rs 350 crore).

• Ebitda up 32% to Rs 89.9 crore (Estimate: Rs 90 crore).

• Ebitda margin expands to 25.7% from 24.2% (Estimate: 25.8%).

• Net profit up 31% to Rs 46.7 crore (Bloomberg estimate: Rs 47 crore).

The company's business-to-consumer revenue growth, at 21%, outpaced overall performance in the July-September period, fuelled by same store growth of 12%, and addition of over 400 new centres. The B2C segment accounts for 56% of the overall revenue.

The business-to-business revenue grew by 13% year-on-year during the quarter. The segment contributes to 35% of the overall revenue.

The revenue from 'TruHealth' segment increased by 23% compared to the year-ago period, according to Metropolis Healthcare.